Drug Delivery Nanocarriers from a Fully Degradable PEG‐Conjugated Polyester with a Reduction‐Responsive Backbone

Abstract

The remarkably high intracellular concentration of reducing agents is an excellent endogenous stimulus for designing nanocarriers programmed for intracellular delivery of therapeutic agents. However, despite their excellent biodegradability profiles, aliphatic polyesters that are fully degradable in response to the intracellular reducing environment are rare. Herein, a reduction-responsive drug delivery nanocarrier derived from a linear polyester bearing disulfide bonds is reported. The reduction-responsive polyester is synthesized via a convenient polycondensation process. After conjugation of terminal carboxylic acid groups of polyester to polyethylene glycol (PEG), the resulting polymer self-assembles into nanoparticles that are capable of encapsulating dye and anticancer drug molecules. The reduction-responsive nanoparticles display a fast payload release rate in response to the intracellular reducing environment, which translates into superior anticancer activity towards PC-3 cells.

Synthesis of a poly(ethylene glycol) galloyl sensitizer tip for an ’all‐in‐one' photodynamic device

“…(ii) There was a greater hydrolytic stability of the PEG‐sensitizer conjugate 1 (ether bond) compared to the labile PEG‐sensitizer conjugates of 2 and 3 (ester bonds). Previously, researchers have examined PEG‐drug conjugates through irreversible ether bonds and reversible ester bonds . (iii) Figure shows the silica tip with CF 3 CF 2 CF 2 CF 2 groups where facile sensitizer release is expected.…”

Targeted Nanoparticles for Colorectal Cancer

“…Polymeric nanoparticles continue to be a popular subject of study in cancer therapy because they are a strong platform with which to encapsulate both hydrophilic and hydrophobic drugs [84][85][86]. However, most drugs are released into the extracellular matrix; their effectiveness depends on diffusion through the tissue, and low in vivo specificity also limits their application [87].…”

Proteína Morfogenética Ósea y su Opción como Tratamiento de la Fisura Alveolar

“…Sin embargo la falta de biocompatibilidad puede promover respuestas celulares no deseadas; aun así, son predecibles y reproducibles en sus resultados. Dicha respuesta "smart" permite determinar la velocidad de degradación y consecuentemente ajustar la tasa de liberación de los fármacos, propiedades físicas, químicas, velocidad de degradación, se pueden fabricar en la forma y tamaño deseado siendo fáciles de esterilizar (Puppi et al;Yameen et al, 2015).…”